Hope for the Future
Immunotherapy remains one of the most active areas of cancer research. Scientists are trying to find ways to make more tumors susceptible to existing immune-based treatments and looking for better biomarkers to predict who will respond to them, as well as exploring entirely new approaches. As is often the case in medicine, the best results may come from combining different strategies. Hundreds of immunotherapy clinical trials are now enrolling participants, and this can be a good way to gain access to these promising new treatments.
